Name | Value |
---|---|
Revenues | 0.0K |
Cost of Revenue | 674.2K |
Gross Profit | -674.2K |
Operating Expense | 16.2K |
Operating I/L | -658.1K |
Other Income/Expense | 495.1K |
Interest Income | 0.0K |
Pretax | -162.9K |
Income Tax Expense | -8.1K |
Net Income/Loss | -154.8K |
Ignyte Acquisition Corp., acquired by Peak Bio Co., Ltd., focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with businesses in the life sciences, biotechnology, and healthcare sectors. With no significant operations of its own, the company aims to generate revenue through strategic partnerships and investments in these targeted industries.